Blood Protein Disease, also known as blood protein disorders, is related to sickle cell disease and monoclonal gammopathy of uncertain significance. An important gene associated with Blood Protein Disease is MYOM2 (Myomesin 2), and among its related pathways/superpathways are Response to elevated platelet cytosolic Ca2+ and Mesenchymal Stem Cells and Lineage-specific Markers. The drugs Bortezomib and Cyclophosphamide have been mentioned in the context of this disorder. Affiliated tissues include liver, and related phenotypes are cellular and immune system